CME Group Inc. $CME Stock Position Boosted by Ameriprise Financial Inc.

Posted by Defense World Staff on Mar 15th, 2026

Ameriprise Financial Inc. raised its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,812,914 shares of the financial services provider’s stock after buying an additional 130,848 shares during the period. Ameriprise Financial Inc. owned approximately 1.33% of CME Group worth $1,300,450,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. MBM Wealth Consultants LLC boosted its holdings in shares of CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 37 shares in the last quarter. West Family Investments Inc. lifted its position in CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 37 shares during the period. Rehmann Capital Advisory Group increased its position in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares during the period. Atlatl Advisers LLC increased its position in shares of CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares during the period. Finally, Verus Capital Partners LLC raised its stake in shares of CME Group by 0.6% in the 3rd quarter. Verus Capital Partners LLC now owns 7,025 shares of the financial services provider’s stock worth $1,898,000 after buying an additional 40 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the sale, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. This trade represents a 8.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Dennis Suskind sold 748 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares in the company, valued at approximately $809,700. This represents a 21.70% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 5,248 shares of company stock worth $1,616,700. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.1%

Shares of NASDAQ:CME opened at $311.40 on Friday. The firm has a 50 day simple moving average of $295.80 and a 200 day simple moving average of $278.99. CME Group Inc. has a 52 week low of $248.53 and a 52 week high of $329.16. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The company has a market cap of $112.29 billion, a PE ratio of 27.90, a price-to-earnings-growth ratio of 3.36 and a beta of 0.24.

CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.75 by $0.02. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The company’s revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the business earned $2.52 EPS. As a group, research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio is 46.59%.

Wall Street Analysts Forecast Growth

CME has been the subject of several research reports. Rothschild & Co Redburn raised their target price on CME Group from $333.00 to $347.00 and gave the company a “neutral” rating in a research note on Thursday. Raymond James Financial reduced their price objective on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Barclays lifted their price objective on shares of CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. increased their target price on shares of CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research note on Thursday, February 5th. Finally, TD Cowen increased their price objective on CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $303.53.

View Our Latest Stock Analysis on CME

Key CME Group News

Here are the key news stories impacting CME Group this week:

Positive Sentiment: Rothschild & Co Redburn raised its price target on CME to $347 (maintaining a “neutral” rating), implying roughly double-digit upside from recent levels and offering fresh analyst support for the shares. Rothschild Co Redburn adjusts price target on CME to 347 from 333, maintains neutral rating
Neutral Sentiment: CME’s CEO Terry Duffy publicly warned that U.S. government intervention in oil futures markets would be highly damaging; exchanges including CME have voiced opposition to potential Treasury action. This raises policy/regulatory risk for energy derivatives but also underscores the exchange’s central role in market integrity — a factor that can support trading volumes in energy products if volatility rises. US intervention in oil futures would be ‘biblical disaster’, CME warns CME Group CEO warns against US intervention in oil futures markets US intervention in oil futures market could be disastrous: CME Group
Neutral Sentiment: Short-interest reporting in recent feeds shows zero or nonsensical values and appears to be a data anomaly rather than a real bearish signal; treat those short-interest items with caution. (Market impact minimal until corrected.)
Negative Sentiment: Insider selling: Ken Vroman (Chief Transformation Officer) sold about 5,160 shares (~$1.59M) and SEC filings show multiple recent insider sales across senior staff. While insider sales can be routine, the cadence and size may raise governance/owner-sentiment questions for some investors. CME Group’s Vroman sells $1.59 million in stock Insider Sale: Chief Transformation Officer of $CME Sells 5,160 Shares

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.